Hi, all,
Curious to learn more about how others are approaching this shortage. It seems our substitution amongst Brands is becoming more limited as the shortage expands.
There are many helpful insights directly from ACOG; however, it is unclear that supply will replenish before additional measures may be needed. Has anyone explored the concept of repackaging the 15,000 units/13 mL Liquid for Injection per USP/Stability information (does supporting information exist)?
https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologi....
https://www.acog.org/clinical/clinical-guidance/practice-advisory/articl...
Thank you,
Zach